NYSE:EBS   Emergent Biosolutions, Inc.
Just broke trend, but long-term support below. I expect it to bounce and backtest the old trend, but no clue after. Could fall to $40 fib then maybe lower.

I love this as a long at some point though. Company got bad press and missed a COVID vaccine delivery after a factory was shut down. It's open now though and they still have a huge backlog of business and 4 years of revenue growth.
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。